Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Cancer Chemotherapy and Pharmacology
|
March 25, 2011
A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors
George R Simon, Robert L Ilaria, Mika A Sovak, et al.
ACS Chemical Biology
|
June 16, 2017
Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth
Thapi Dharma Rao, Alberto Fernández-Tejada, Abram Axelrod, et al.
Investigational New Drugs
|
November 11, 2011
Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma
Jason Konner, Rachel N Grisham, Jae Park, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 15, 2018
A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer
Katherine LaVigne, David M Hyman, Qin C Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2007
Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer
Paul J Sabbatini, Govind Ragupathi, Chandra Hood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 2, 2009
Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors
A Craig Lockhart, Mace L Rothenberg, Jakob Dupont, et al.
Journal of Ovarian Research
|
April 2, 2024
Sialyl-Tn serves as a potential therapeutic target for ovarian cancer
Linah Al-Alem, Jillian M Prendergast, Justin Clark, et al.
British Journal of Cancer
|
May 26, 2018
Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials
Tomoya Yokota, Johanna Bendell, Patricia LoRusso, et al.
Cancer Chemotherapy and Pharmacology
|
February 13, 2015
Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors
David M Hyman, Alexandra E Snyder, Richard D Carvajal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 20, 2019
Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma
Yanxia Zhao, Jinghong Cao, Alexander Melamed, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Cancer Chemotherapy and Pharmacology
|
March 25, 2011
A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors
George R Simon, Robert L Ilaria, Mika A Sovak, et al.
ACS Chemical Biology
|
June 16, 2017
Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth
Thapi Dharma Rao, Alberto Fernández-Tejada, Abram Axelrod, et al.
Investigational New Drugs
|
November 11, 2011
Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma
Jason Konner, Rachel N Grisham, Jae Park, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 15, 2018
A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer
Katherine LaVigne, David M Hyman, Qin C Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2007
Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer
Paul J Sabbatini, Govind Ragupathi, Chandra Hood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 2, 2009
Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors
A Craig Lockhart, Mace L Rothenberg, Jakob Dupont, et al.
Journal of Ovarian Research
|
April 2, 2024
Sialyl-Tn serves as a potential therapeutic target for ovarian cancer
Linah Al-Alem, Jillian M Prendergast, Justin Clark, et al.
British Journal of Cancer
|
May 26, 2018
Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials
Tomoya Yokota, Johanna Bendell, Patricia LoRusso, et al.
Cancer Chemotherapy and Pharmacology
|
February 13, 2015
Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors
David M Hyman, Alexandra E Snyder, Richard D Carvajal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 20, 2019
Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma
Yanxia Zhao, Jinghong Cao, Alexander Melamed, et al.
Page
of 7